CONCLUSIONS	Despite the ineffectiveness on reduction of delayed cerebral ischemia or poor functional outcome , intraventricular fibrinolysis and kinetic therapy seems to be a safe and effective concept for therapeutic reduction of subarachnoid clot in a patient collective experiencing predominantly severe subarachnoid hemorrhage .\